BioXcel Therapeutics (BTAI) Reports Q4 Loss of $0.87/sh
BioXcel Therapeutics (NASDAQ: BTAI) reported Q4 EPS of ($0.87), versus ($0.45) reported last year.
For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.
BioXcel Therapeutics (NASDAQ: BTAI) reported Q4 EPS of ($0.87), versus ($0.45) reported last year.
For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.